Header Logo

Connection

VIKAS KUNDRA to Humans

Back to Details
This is a "connection" page, showing publications VIKAS KUNDRA has written about Humans.
VIKAS KUNDRA
Connection Strength
0.608
Humans
  1. Abdominal visceral tuberculosis: a malignancy mimic. Abdom Radiol (NY). 2023 08; 48(8):2705-2715.
    View in: PubMed
    Score: 0.018
  2. Hybrid magnetic resonance and PET imaging for prostate cancer recurrence. Curr Opin Oncol. 2023 05 01; 35(3):231-238.
    View in: PubMed
    Score: 0.018
  3. Tuberculosis of abdominal lymph nodes, peritoneum, and GI tract: a malignancy mimic. Abdom Radiol (NY). 2022 05; 47(5):1775-1787.
    View in: PubMed
    Score: 0.017
  4. Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms. J Comput Assist Tomogr. 2022 May-Jun 01; 46(3):333-343.
    View in: PubMed
    Score: 0.017
  5. Imaging of Kaposi sarcoma. Abdom Radiol (NY). 2021 11; 46(11):5297-5306.
    View in: PubMed
    Score: 0.016
  6. Performance of O-RADS MRI Score for Classifying Indeterminate Adnexal Masses at US. Radiol Imaging Cancer. 2021 05; 3(3):e219008.
    View in: PubMed
    Score: 0.016
  7. Multiparameter MRI and Clinical Factors for Predicting Early Response to Chemoradiotherapy in Cervical Cancer. Radiol Imaging Cancer. 2021 01; 3(1):e209038.
    View in: PubMed
    Score: 0.015
  8. Tuberous Sclerosis Complex (TSC): Renal and Extrarenal Imaging. Acad Radiol. 2022 03; 29(3):439-449.
    View in: PubMed
    Score: 0.015
  9. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade. Cancer Imaging. 2021 Jan 06; 21(1):3.
    View in: PubMed
    Score: 0.015
  10. Radiogenomic Analysis May Complement Staging and Genomic Analysis in Primary Colorectal Cancer for Predictive Modeling of Prognosis. Radiol Imaging Cancer. 2020 09; 2(5):e209027.
    View in: PubMed
    Score: 0.015
  11. Biopsy in Prostate Cancer. More Is Better. Radiol Imaging Cancer. 2020 07; 2(4):e204019.
    View in: PubMed
    Score: 0.015
  12. In vivo magnetic resonance imaging of orthotopic prostate cancer. Biotechniques. 2020 07; 69(1):395-403.
    View in: PubMed
    Score: 0.015
  13. Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed? AJR Am J Roentgenol. 2020 06; 214(6):1248-1258.
    View in: PubMed
    Score: 0.014
  14. Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer. Sci Rep. 2019 04 15; 9(1):6100.
    View in: PubMed
    Score: 0.014
  15. The ABCs of BHD: An In-Depth Review of Birt-Hogg-Dub? Syndrome. AJR Am J Roentgenol. 2017 Dec; 209(6):1291-1296.
    View in: PubMed
    Score: 0.012
  16. In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model. Radiology. 2017 12; 285(3):830-838.
    View in: PubMed
    Score: 0.012
  17. Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients. AJR Am J Roentgenol. 2017 Aug; 209(2):327-332.
    View in: PubMed
    Score: 0.012
  18. Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder. AJR Am J Roentgenol. 2017 Jun; 208(6):1193-1205.
    View in: PubMed
    Score: 0.012
  19. Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer? J Magn Reson Imaging. 2017 04; 45(4):1216-1224.
    View in: PubMed
    Score: 0.011
  20. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. 2016 Feb; 43(2):316-24.
    View in: PubMed
    Score: 0.010
  21. Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One. 2015; 10(6):e0131095.
    View in: PubMed
    Score: 0.010
  22. Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 2015 May; 204(5):1031-41.
    View in: PubMed
    Score: 0.010
  23. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2015 Apr; 204(4):W439-48.
    View in: PubMed
    Score: 0.010
  24. Imaging acute complications in cancer patients: what should be evaluated in the emergency setting? Cancer Imaging. 2014 Apr 29; 14:18.
    View in: PubMed
    Score: 0.010
  25. Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT. Abdom Imaging. 2014 Feb; 39(1):66-85.
    View in: PubMed
    Score: 0.009
  26. Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer. Mol Imaging. 2013 Oct; 12(7):1-10.
    View in: PubMed
    Score: 0.009
  27. Imaging features of carcinoid tumors of the gastrointestinal tract. AJR Am J Roentgenol. 2013 Oct; 201(4):773-86.
    View in: PubMed
    Score: 0.009
  28. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know. AJR Am J Roentgenol. 2012 Dec; 199(6):1283-93.
    View in: PubMed
    Score: 0.009
  29. Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2012 Oct; 199(4):822-9.
    View in: PubMed
    Score: 0.009
  30. Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases. Eur Radiol. 2013 Feb; 23(2):400-7.
    View in: PubMed
    Score: 0.009
  31. Common and uncommon bilateral adult renal masses. Cancer Imaging. 2012 May 21; 12:205-11.
    View in: PubMed
    Score: 0.008
  32. Common and uncommon adult unilateral renal masses other than renal cell carcinoma. Cancer Imaging. 2012 May 21; 12:194-204.
    View in: PubMed
    Score: 0.008
  33. Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality. Radiographics. 2011 Nov-Dec; 31(7):1823-32.
    View in: PubMed
    Score: 0.008
  34. Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough? Neuroendocrinology. 2011; 93(4):241-8.
    View in: PubMed
    Score: 0.008
  35. SSTR2-based reporters for assessing gene transfer into non-small cell lung cancer: evaluation using an intrathoracic mouse model. Hum Gene Ther. 2011 Jan; 22(1):55-64.
    View in: PubMed
    Score: 0.008
  36. Diffusion weighted imaging in prostate cancer. Eur Radiol. 2011 Mar; 21(3):593-603.
    View in: PubMed
    Score: 0.008
  37. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One. 2010 Mar 29; 5(3):e9854.
    View in: PubMed
    Score: 0.007
  38. Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases. J Magn Reson Imaging. 2009 May; 29(5):1154-62.
    View in: PubMed
    Score: 0.007
  39. Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging. 2007 Nov-Dec; 6(6):427-37.
    View in: PubMed
    Score: 0.006
  40. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol. 2007 Oct; 189(4):830-44.
    View in: PubMed
    Score: 0.006
  41. In vivo imaging of prostate cancer involving bone in a mouse model. Prostate. 2007 Jan 01; 67(1):50-60.
    View in: PubMed
    Score: 0.006
  42. Prostate cancer imaging. Semin Roentgenol. 2006 Apr; 41(2):139-49.
    View in: PubMed
    Score: 0.005
  43. Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology. 2005 Jun; 235(3):950-8.
    View in: PubMed
    Score: 0.005
  44. Telomerase activity predicts malignancy in percutaneous image-guided needle biopsy specimens of the abdomen and pelvis. Radiology. 2005 Mar; 234(3):941-7.
    View in: PubMed
    Score: 0.005
  45. Testicular cancer. Semin Roentgenol. 2004 Jul; 39(3):437-50.
    View in: PubMed
    Score: 0.005
  46. Impact of multislice CT on imaging of acute abdominal disease. Radiol Clin North Am. 2003 Nov; 41(6):1083-93.
    View in: PubMed
    Score: 0.005
  47. Real-Time Ultrasound-Computed Tomography Fusion with Volume Navigation to Assess Pancreatic Cystic Lesions. Curr Oncol. 2023 09 13; 30(9):8375-8385.
    View in: PubMed
    Score: 0.005
  48. Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2024 Apr; 7(2):189-203.
    View in: PubMed
    Score: 0.005
  49. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol. 2003 Apr; 180(4):1045-54.
    View in: PubMed
    Score: 0.004
  50. Prostate cancer grade downgrading at time of prostatectomy provides risk-stratification insight into future tumor behavior after prostatectomy. Prostate. 2022 12; 82(16):1520-1528.
    View in: PubMed
    Score: 0.004
  51. Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med. 2002 Mar; 43(3):406-12.
    View in: PubMed
    Score: 0.004
  52. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer. Eur Urol Oncol. 2022 04; 5(2):164-175.
    View in: PubMed
    Score: 0.004
  53. CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance. Cell Rep. 2021 08 17; 36(7):109549.
    View in: PubMed
    Score: 0.004
  54. REST promotes ETS1-dependent vascular growth in medulloblastoma. Mol Oncol. 2021 05; 15(5):1486-1506.
    View in: PubMed
    Score: 0.004
  55. Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. Int J Cancer. 2021 04 15; 148(8):1928-1937.
    View in: PubMed
    Score: 0.004
  56. Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI) - Part I - Tumor Response Criteria and Established Functional Imaging Techniques. Semin Ultrasound CT MR. 2021 Apr; 42(2):201-214.
    View in: PubMed
    Score: 0.004
  57. Advanced Imaging in Musculoskeletal Oncology: Moving Away From RECIST and Embracing Advanced Bone and Soft Tissue Tumor Imaging (ABASTI)-Part II-Novel Functional Imaging Techniques. Semin Ultrasound CT MR. 2021 Apr; 42(2):215-227.
    View in: PubMed
    Score: 0.004
  58. Virus-Mimicking Nanoparticles for Targeted Near Infrared Fluorescence Imaging of Intraperitoneal Ovarian Tumors in Mice. Ann Biomed Eng. 2021 Feb; 49(2):548-559.
    View in: PubMed
    Score: 0.004
  59. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. Clin Cancer Res. 2020 09 15; 26(18):4933-4946.
    View in: PubMed
    Score: 0.004
  60. Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage. Mol Pharm. 2019 02 04; 16(2):808-815.
    View in: PubMed
    Score: 0.003
  61. Whole-body MRI in pediatric patients with cancer. Cancer Imaging. 2017 Feb 10; 17(1):6.
    View in: PubMed
    Score: 0.003
  62. Ocular extramedullary myeloid leukaemia. Br J Haematol. 2018 03; 180(5):738-740.
    View in: PubMed
    Score: 0.003
  63. Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction. J Appl Clin Med Phys. 2016 11 08; 17(6):334-342.
    View in: PubMed
    Score: 0.003
  64. Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients. Eur Radiol. 2017 Feb; 27(2):543-552.
    View in: PubMed
    Score: 0.003
  65. Performance evaluation of iterative reconstruction algorithms for achieving CT radiation dose reduction - a phantom study. J Appl Clin Med Phys. 2016 03 08; 17(2):511-531.
    View in: PubMed
    Score: 0.003
  66. Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis. Oncotarget. 2015 Nov 17; 6(36):38816-26.
    View in: PubMed
    Score: 0.003
  67. Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors. Nanotechnology. 2015 Oct 30; 26(43):435102.
    View in: PubMed
    Score: 0.003
  68. PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Invest New Drugs. 2015 Apr; 33(2):271-9.
    View in: PubMed
    Score: 0.003
  69. Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Sci Transl Med. 2014 Sep 03; 6(252):252ra122.
    View in: PubMed
    Score: 0.002
  70. Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells. Lasers Surg Med. 2014 Sep; 46(7):582-92.
    View in: PubMed
    Score: 0.002
  71. Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol. 2014 Mar; 202(3):544-52.
    View in: PubMed
    Score: 0.002
  72. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature. 1994 Feb 03; 367(6462):474-6.
    View in: PubMed
    Score: 0.002
  73. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence. Magn Reson Imaging. 2013 Jun; 31(5):669-75.
    View in: PubMed
    Score: 0.002
  74. Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427.
    View in: PubMed
    Score: 0.002
  75. Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer. Gynecol Oncol. 2012 Jul; 126(1):47-53.
    View in: PubMed
    Score: 0.002
  76. Effect of transforming growth factor beta (TGF-?) receptor I kinase inhibitor on prostate cancer bone growth. Bone. 2012 Mar; 50(3):695-703.
    View in: PubMed
    Score: 0.002
  77. Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models. Mol Cancer Ther. 2011 Dec; 10(12):2350-62.
    View in: PubMed
    Score: 0.002
  78. Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging. 2012 Feb; 35(2):399-408.
    View in: PubMed
    Score: 0.002
  79. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol. 2011 Nov; 12(12):1109-17.
    View in: PubMed
    Score: 0.002
  80. Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One. 2011; 6(6):e21250.
    View in: PubMed
    Score: 0.002
  81. Fast three-dimensional dual echo dixon technique improves fat suppression in breast MRI. J Magn Reson Imaging. 2010 Apr; 31(4):889-94.
    View in: PubMed
    Score: 0.002
  82. NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clin Cancer Res. 2009 Mar 15; 15(6):2130-9.
    View in: PubMed
    Score: 0.002
  83. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest. 2008 Aug; 118(8):2697-710.
    View in: PubMed
    Score: 0.002
  84. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity. Cancer Res. 2008 Jan 01; 68(1):206-15.
    View in: PubMed
    Score: 0.002
  85. Pharmacodynamic markers of perifosine efficacy. Clin Cancer Res. 2007 Dec 15; 13(24):7421-31.
    View in: PubMed
    Score: 0.002
  86. Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res. 2007 Oct 01; 67(19):9337-45.
    View in: PubMed
    Score: 0.002
  87. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia. 2007 Jun; 9(6):479-86.
    View in: PubMed
    Score: 0.001
  88. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res. 2006 Oct 01; 66(19):9682-90.
    View in: PubMed
    Score: 0.001
  89. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006 Aug; 12(8):939-44.
    View in: PubMed
    Score: 0.001
  90. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006 Mar; 9(3):225-38.
    View in: PubMed
    Score: 0.001
  91. Isolation of a mouse cDNA encoding mSTI1, a stress-inducible protein containing the TPR motif. Gene. 1997 Jul 31; 194(2):277-82.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.